Hematopoietic and Lung Platelet Biogenesis as a Prognostic Indicator in Idiopathic Pulmonary Fibrosis
Am J Respir Crit Care Med
.
2022 Nov 1;206(9):1174-1177.
doi: 10.1164/rccm.202206-1195LE.
Authors
Shigeki Saito
1
,
Cheng Han H Chung
1
,
Alex Jacob
1
,
Nebil Nuradin
1
,
Amy E Meyer
1
,
Haoran Yang
1
,
Jay K Kolls
1
,
Victor J Thannickal
1
,
Joseph A Lasky
1
,
Toshie Saito
2
,
Yao-Zhong Liu
3
Affiliations
1
Tulane University School of Medicine New Orleans, Louisiana.
2
Stanford University School of Medicine Stanford, California.
3
Tulane University School of Public Health and Tropical Medicine New Orleans, Louisiana.
PMID:
35853164
PMCID:
PMC9704823
DOI:
10.1164/rccm.202206-1195LE
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
Humans
Idiopathic Pulmonary Fibrosis*
Lung
Prognosis
Thorax
Grants and funding
K08 HL146979/HL/NHLBI NIH HHS/United States
R01 HL152246/HL/NHLBI NIH HHS/United States
R35 HL139930/HL/NHLBI NIH HHS/United States
R38 HL155774/HL/NHLBI NIH HHS/United States